Market Overview - The Shanghai Composite Index rose by 0.05% on January 7, with 17 out of the industries under Shenwan showing gains, led by the comprehensive and coal industries, which increased by 3.86% and 2.47% respectively [1] - The oil and petrochemical and non-bank financial industries experienced the largest declines, falling by 1.73% and 1.13% respectively [1] Capital Flow Analysis - The main capital flow showed a net outflow of 54.336 billion yuan across the two markets, with only four industries seeing net inflows [1] - The telecommunications industry had the highest net inflow, amounting to 4.752 billion yuan, and it rose by 1.24% [1] - The coal industry also saw a net inflow of 1.870 billion yuan, with a daily increase of 2.47% [1] Comprehensive Industry Insights - The comprehensive industry saw a rise of 3.86% with a net inflow of 279 million yuan, comprising 15 stocks, of which 5 rose and 1 hit the daily limit [2] - The top stock in terms of net inflow was Dongyangguang, with an inflow of 327 million yuan, followed by Sanmu Group and Zhangzhou Development with inflows of 42.344 million yuan and 19.784 million yuan respectively [2] - The stocks with the highest net outflows included Yuegui Co., Nanjing Xinbai, and Tianchen Co., with outflows of 74.420 million yuan, 18.580 million yuan, and 17.936 million yuan respectively [2] Comprehensive Industry Stock Performance - The top-performing stocks in the comprehensive industry included: - Dongyangguang: +10.00% with a turnover rate of 3.54% and a main capital flow of 326.6386 million yuan [2] - Sanmu Group: +4.42% with a turnover rate of 17.50% and a main capital flow of 42.3443 million yuan [2] - Zhangzhou Development: +0.38% with a turnover rate of 5.64% and a main capital flow of 19.7843 million yuan [2] - Stocks with negative performance included: - Yuegui Co.: -1.90% with a turnover rate of 10.82% and a net outflow of 74.4204 million yuan [2] - Nanjing Xinbai: -1.13% with a turnover rate of 2.95% and a net outflow of 18.5800 million yuan [2] - Tianchen Co.: -0.56% with a turnover rate of 8.24% and a net outflow of 17.9362 million yuan [2]

Core Viewpoint - The company announces the resignation of two directors, Shang Haibin and Huang Jian, due to organizational arrangements and work changes respectively [1] Group 1 - Director Shang Haibin resigns from his position as a board member and audit committee member, which will lead to insufficient members in the audit committee [1] - Shang Haibin's resignation report will take effect after the shareholders' meeting elects a new director [1] - Director Huang Jian resigns from his board position due to work changes, with his resignation report effective upon delivery to the board [1]

证券代码：000421 证券简称：南京公用 公告编号：2025-71 南京公用发展股份有限公司 关于董事辞职的公告 商海彬先生、黄坚先生在担任公司董事期间勤勉尽责、恪尽职守，为促进 公司规范运作和健康发展发挥了积极的作用。公司及董事会对商海彬先生、黄 坚先生在任职期间对公司发展所作出的贡献表示衷心的感谢！ 特此公告。 南京公用发展股份有限公司董事会 2025 年 12 月 31 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 南京公用发展股份有限公司（以下简称"公司"）董事会近日收到公司董 事商海彬先生、黄坚先生的辞职报告。商海彬先生因组织安排，申请辞去公司 董事以及审计委员会委员职务；黄坚先生因工作变动，申请辞去公司董事职务。 商海彬先生、黄坚先生辞职后不再在公司及控股子公司担任任何职务。 商海彬先生、黄坚先生原定的任职期间至公司第十二届董事会任期届满之 日止。根据《公司法》《公司章程》等相关规定，黄坚先生的辞职不会导致公 司董事会成员低于法定人数，不会影响公司董事会正常运作和公司正常生产经 营，其辞职报告自送达董事会时生效。商海彬先生的辞职不会导致公司 ...

Transaction Overview - The company announced the transfer of 51% equity in its subsidiary, Nanjing Zhongbei Jinjia Real Estate Development Co., Ltd. (hereinafter referred to as "Zhongbei Jinjia"), through a public listing, with a final transaction price of RMB 34.84237 million [1][4] - The transfer was approved by the company's board and shareholders, and the transaction does not constitute a related party transaction or a major asset restructuring as per regulations [2][6][7] - The transaction is part of the company's strategy to optimize resource allocation and improve asset operation efficiency [22] Financial Details - The assessed value of the 51% equity stake was RMB 34.5238 million, based on the total equity value of RMB 67.6937 million as of August 31, 2025 [3][13] - The transaction price was slightly above the assessed value, indicating a successful sale [4][13] - The buyer, Nanjing Jinjia Enterprise Management Co., Ltd., is a wholly-owned subsidiary of Nanjing Jinjia Tongchan Real Estate Co., Ltd. [8][11] Impact on Company - Following the completion of the transaction, Zhongbei Jinjia will no longer be included in the company's consolidated financial statements, which is expected to enhance the liquidity of the company's assets and improve overall operational efficiency [5][22] - The company will adhere to relevant accounting standards for the transaction, with the actual financial impact to be confirmed by annual audits [22]

证券代码：000421 股票简称：南京公用 公告编号：2025-69 南京公用发展股份有限公司 关于全资子公司通过挂牌方式转让其控股子公司南 京中北金基房地产开发有限公司 51%股权的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、南京公用发展股份有限公司（以下简称"公司"）全资子公司南京中北 盛业房地产开发有限公司（以下简称"中北盛业"）通过公开挂牌方式转让持有 的南京中北金基房地产开发有限公司（以下简称"中北金基房地产"）51%股权。 2025 年 12 月 24 日，根据南京市公共资源交易中心（以下简称"鉴证方"）出具 的受让方确认函，在规定期限内仅有南京金基企业管理有限公司（以下简称"金 基企管"）完成报名并缴纳了保证金，根据南京市公共资源交易中心相关交易规 则，本次交易最终成交价格确定为 3,484.237 万元。 本次交易完成后，中北金基房地产将不再纳入公司合并报表范围。 2、本次交易不构成关联交易，也不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 3、截至本公告披露日，本次交易双方已正式签订了《产权交易 ...

证券代码：000421 证券简称：南京公用 公告编号：2025-70 南京公用发展股份有限公司 关于收回对外财务资助部分款项的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、财务资助情况概述 南京朗鑫樾置业有限公司（以下简称"朗鑫樾"）系南京公用发展股份有限公司 （以下简称"公司"）全资子公司南京中北盛业房地产开发有限公司（以下简称"中 北盛业"）的参股公司，中北盛业持有朗鑫樾45%股权，南京朗福地产有限公司（以 下简称"南京朗福"）持有朗鑫樾30%股权，江苏洛德股权投资基金管理有限公司（以 下简称"洛德基金"）持有朗鑫樾25%股权。朗鑫樾目前主要业务系南京江宁 NO.2017G62项目地块（以下简称"NO.2017G62项目"）的开发建设及销售。 为满足朗鑫樾开发的NO.2017G62项目运营和管理所需的资金需求，经2017年11 月13日召开的第九届董事会第二十四次会议、2017年11月29日召开的2017年第一次 临时股东大会审议通过，中北盛业于NO.2017G62项目开发初始阶段按照同股同权的 原则，以股东借款形式向朗鑫樾提供了不超过70,8 ...

Group 1 - Zhuolang Intelligent's subsidiary plans to increase capital by 900 million yuan to its wholly-owned subsidiary in Xinjiang [1] - Zhenhua Heavy Industry signed a contract worth 1.149 billion yuan with Guangzhou Salvage Bureau for a deep-water crane ship construction project [2] - Ugreen Technology intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy [3] Group 2 - Guangsheng Nonferrous Metals will change its stock name to Zhongxi Rare Metals starting December 31, 2025 [4] - China Electric Research proposed a cash dividend of 2.5 yuan per 10 shares for the first three quarters of 2025 [5] - Chaoyan Co. is establishing a fund with professional investment institutions, aiming to raise 1 billion yuan [6] Group 3 - Silk Road Vision's subsidiary plans to sell 8.5% of Ruijun Technology for 52.7 million yuan [7] - Longgao Co.'s actual controller is transferring 4.37% of the investment development group's equity for 398 million yuan [8] - Weiteou signed a strategic cooperation agreement with Huaruixin Energy to develop new materials and applications [9][10] Group 4 - Annuoqi decided to terminate the investment in a 50,000-ton dye intermediate project due to market changes, with a total investment of 421 million yuan [12] - Akoli's subsidiary has entered trial production for a project with an annual capacity of 20,000 tons of polyether amine [13] - Ningbo Construction's subsidiary signed a construction contract worth 451 million yuan for a comprehensive utility tunnel project [14] Group 5 - Zhejiang Rongtai and Weichuang Electric plan to establish a joint venture in Thailand for R&D and production of mechatronic components [15] - Jiuzhoutong's subsidiary received a drug registration certificate for isopropazine injection [16] - Huaqin Technology's subsidiary signed a daily operation contract worth 392 million yuan [17] Group 6 - ST Meichen completed the sale of 100% equity in Hainan Meichen Ecological Development Co., Ltd. [18] - Pulite's LCP film products have begun mass production for a leading customer in the consumer electronics industry [19][20] - Nanjing Public Utility's major shareholder transferred 7.61% of the company's shares for 300 million yuan [21] Group 7 - Solar Energy terminated the investment in a 150 MW distributed photovoltaic project due to increased investment risks [22] - Yuntian Lifa won a 122 million yuan project for AI development in Longgang [23] - Changchun High-tech's subsidiary received acceptance for a clinical trial application for GenSci141 ointment [24] Group 8 - Changfei Optical Fiber's major shareholder completed a share reduction plan, selling 1.1 million shares for approximately 104.5 million yuan [25] - Sandam Membrane plans to apply for a comprehensive credit limit of up to 100 million yuan for 2026 [26] - Aisecurity received a government subsidy of 3.4611 million yuan [27] Group 9 - Stone Technology's H-share issuance has received approval from the China Securities Regulatory Commission [28] - Hongxing Development's subsidiary plans to suspend production to comply with national hazardous chemical relocation policies [29] - Guodian Nanzi's vice president and chief engineer resigned [30] Group 10 - Jianghe Group's subsidiary won a bid for a city renovation project in Haikou worth approximately 112 million yuan [31] - Gaotie Electric's subsidiary won a bid for a railway project worth 59.0317 million yuan [32] - Huicheng Co. plans to introduce a new partner to its major shareholder [33] Group 11 - Pumen Technology's folic acid testing kit received a medical device registration certificate [34] - Hai Xin Co.'s vitamin B6 injection passed the consistency evaluation for generic drugs [35] - Taiji Group's shareholder plans to merge with its subsidiary [36] Group 12 - Shengyi Electronics adjusted the maximum repurchase price to no more than 144.36 yuan per share [37]

证券代码：000421 证券简称：南京公用 公告编号：2025-68 南京公用发展股份有限公司 及相关简式权益变动报告书。 2025 年 12 月 10 日，公司收到控股股东转发的江苏省政府国有资产监督管理委 员会（以下简称"江苏省国资委"）《江苏省国资委关于同意南京城建集团及其子 公司非公开协议转让所持南京公用 7.61%股权的批复》（苏国资复[2025]67 号）， 主要内容如下：原则同意该国有股权变动事项，即城建集团通过非公开协议转让方 式，向创投集团转让所持有的上市公司南京公用 26,930,936 股股份、占上市公司总 股本的 4.69%；公用控股通过非公开协议转让方式，向创投集团转让所持有的上市 公司南京公用 16,800,064 股股份、占上市公司总股本的 2.92%。 关于控股股东及其一致行动人协议转让公司部分股份完 成过户登记的公告 本公司及董事会全体成员保证公告内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 南京公用发展股份有限公司（以下简称"公司"）于近日收到公司控股股东南 京公用控股（集团）有限公司（以下简称"公用控股"）及其一致行动人南京市城 市建设投资控股（集团）有 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 一、交易概述 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1、南京公用发展股份有限公司（以下简称"公司"）全资子公司南京中北盛业房地产开发有限公司（以 下简称"中北盛业"）通过公开挂牌方式转让持有的南京中北金基企悦企业管理咨询有限公司（以下简 称"中北金基企悦"）45%股权。2025年12月16日，根据南京市公共资源交易中心（以下简称"鉴证方"） 出具的受让方确认函，在规定期限内仅有南京金基新企悦企业管理咨询有限公司（以下简称"金基新企 悦"）完成报名并缴纳了保证金，根据南京市公共资源交易中心相关交易规则，本次交易最终成交价格 确定为2,364.43万元。 2、本次交易不构成关联交易，也不构成《上市公司重大资产重组管理办法》规定的重大资产重组。 3、截至本公告披露日，本次交易双方已正式签订了《产权交易合同》并完成了交易价款的全额支付工 作，尚需向主管市场监督管理部门办理股权变更登记等手续。公司将持续关注本次公开挂牌转让事项的 相关进展情况，严格按照有关法律法规及规范性文件的要求及时履行信息披 ...

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]